ÂÜÀòÂÒÂ×

Brian Powl has extensive work experience in the pharmaceutical industry. Brian is currently serving as the Chief Commercial Officer at Kura Oncology, Inc. Prior to this, they held the same position at Fate Therapeutics Inc. from 2022 to 2023. From 2020 to 2022, Brian worked as the Senior Vice President of Marketing at MEI Pharma. Brian'sprevious role at Celgene included positions such as Vice President Global Commercial CAR T Lead, Vice President Global Marketing Portfolio Execution Hem/Onc, Executive Director Global Marketing Lead Multiple Myeloma, Senior Director Global Marketing Solid Tumors, and Director Strategic Marketing Solid Tumors. Brian also had various roles at Novartis Oncology, including Associate Director, US NET Alliance Marketing, Oncology Sales Specialist, and Associate Director, New Product Strategy. Brian began their career at Centocor (J&J) as a Senior Manager from 2003 to 2006.

Brian Powl's education history is as follows: they obtained a Bachelor of Science degree in Biochemistry from UC San Diego, where they attended from 1991 to 1995. Later, they pursued a Master of Business Administration (MBA) degree with a focus on Marketing/Health Care Management at The Wharton School, which they completed from 2001 to 2003.